English: Simplified graphical representation of a cross-section of the Hepatitis B virus particle and surface (surplus) antigen, the hepatitis B e antigens (HBcAg) shown are considered not part of the viral particle (quod videviral nonstructural protein). The structure of the Hepatitis B virus as first described by Dane & al.[1] and Jokelainen, Krohn & al.[2] during 1970. The hepatitis B virion is a complex, double shelled, spherical particle with a 42 nm diameter.[1][2][3]
The 6 nm[2] thick outer viral envelope or membrane contains host-derived lipids and surface proteins,[2] known collectively as HBsAg.[3] The membrane contains globular subunits each measuring ca. 3 to 4 nm in diameter and 3 to 4 nm apart.[2]
Within the membrane sphere is a 2 nm thick icosahedralnucleocapsid inner core composed of protein (HBcAg) with a 27 nm diameter.[2] When viewed through an electron microscope the inner core may appear pentagonal or hexagonal,[2] depending on the relative position of the sample.
The nucleocapsid contains a viral genome[2] of circular, partially double stranded DNA[3] and endogenous DNA polymerase[4][3] within a diameter of ca. 18 nm.[2]
The virion was initially referred to as the Dane particle.[4] Only after Baruch Blumberg received the Nobel Prize in Medicine during 1976 was it universally accepted that the particle is a virus and the infectious agent of Hepatitis B.
Australiaantigen (HBsAg): The serum of infected patients contain small spherical and rod-shaped particles with a diameter of ca. 20 nm,[5] consisting of surplus virus-coat material containing the HBsAg antigen.[1][2] This antigen was first discovered by Baruch Blumberg during 1965 within the blood of Australian aboriginal people and initially known as "Australia antigen".[6] It was shown to be associated with "serum hepatitis" by A. M. Prince during 1968.[7]
The outer membrane of the virion is sometimes extended as a tubular tail on one side of the virus particle (not shown);[2][3] these virion "tails" are identical to the small particles.[2][3]
This biology image could be re-created using vector graphics as an SVG file. This has several advantages; see Commons:Media for cleanup for more information. If an SVG form of this image is available, please upload it and afterwards replace this template with {{vector version available|new image name}}.
It is recommended to name the SVG file “Hepatitis B virus v2.svg”—then the template Vector version available (or Vva) does not need the new image name parameter.
In case this is not legally possible: TimVickers grants anyone the right to use this work for any purpose, without any conditions, unless such conditions are required by law.
Original upload log
The original description page was here. All following user names refer to en.wikipedia.
2007-11-14 18:14 TimVickers 843×577× (81917 bytes) Simplified drawing of the Hepatitis B virus particle and surface (surplus) antigen
Sources
↑ abcD.S. Dane , C.H. Cameron , Moya Briggs (1970). "Virus-Like Particles in Serum of Patients with Australia-Antigen-Associated Hepatitis". The Lancet295: 695–698. DOI:10.1016/S0140-6736(70)90926-8.
↑ abAlmeida J D, Rubenstein D & Scott E J. (1971). "New antigen-antibody system in Australia-antigen-positive hepatitis". The Lancet298 (7736): 1225–7. DOI:10.1016/S0140-6736(71)90543-5.
↑Bayer, M. E., B. S. Blumberg, and B. Werner (1968). "Particles associated with Australia antigen in the sera of patients with leukemia, Down's syndrome and hepatitis.". Nature (London)218: 1057-1059.
{{Information |Description={{en|Simplified drawing of the Hepatitis B virus particle and surface (surplus) antigen. Created by en:User:GrahamColm}} |Source=Transferred from [http://en.wikipedia.org en.wikipedia] |Date=2007-11-14 (original upload date